5 • 716 Ratings
🗓️ 4 December 2025
⏱️ 15 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Moxifloxacin is a fourth-generation fluoroquinolone that works by inhibiting bacterial DNA gyrase and topoisomerase IV—two enzymes essential for DNA replication, repair, and transcription. By blocking both targets, it provides broad-spectrum activity against gram-positive, gram-negative, and atypical pathogens. Its enhanced gram-positive coverage, especially against Streptococcus pneumoniae, distinguishes it from earlier fluoroquinolones like ciprofloxacin.
Pharmacokinetically, moxifloxacin has excellent oral bioavailability, meaning the PO and IV doses are essentially interchangeable. It distributes well into tissues like the lungs and sinuses, making it a frequent choice for respiratory infections. With a long half-life of about 12 hours, once-daily dosing is standard.
Adverse effects are similar to the fluoroquinolone class, with concerns including tendonitis and tendon rupture, QT interval prolongation, CNS effects like confusion or agitation—particularly in older adults—and the risk of peripheral neuropathy. Moxifloxacin is especially notable for a higher propensity toward QT prolongation compared with some of its peers, making it important to avoid in patients with existing QT issues or those taking other QT-prolonging medications.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)
Guide to Drug Food Interactions (Amazon Best Seller)
Click on a timestamp to play from that location
| 0:00.0 | Hey, all, welcome back to the Real Life Pharmacology podcast. I'm your host, pharmacist, Eric Christensen. |
| 0:05.7 | Thank you so much for listening today. As always, go check out our top 200 study guide. |
| 0:13.1 | It's a great refresher. If you're out in practice, if you're going through pharmacology courses, |
| 0:18.0 | anybody could definitely benefit from this. So it's, again, our top 200 study |
| 0:22.7 | guide. You can find that at real life pharmacology.com. It is a 31-page PDF, and it's filled with some |
| 0:29.6 | of the most important things I've seen show up on pharmacology exams throughout my career, as well as a |
| 0:35.8 | lot of those things that actually happen in real-life practice. All right. Well, we are going to get into the drug of the day, and that is moxifloxasin. Brand name of this medication is Avalox, and this is classified as a fluoroquinolone antibiotic. |
| 0:57.6 | More specifically, in school and throughout my career, I've always heard this medication as more of a respiratory fluoroquinolone. |
| 1:08.1 | And I'll explain the reason for that, but I want to cover the mechanism of |
| 1:13.8 | action first. So topolysomerase, this is an important enzyme for maintaining bacterial DNA structure. |
| 1:28.5 | Okay. |
| 1:28.9 | So what moxifloxin does is it inhibits topo isomerase, |
| 1:35.3 | and specifically topolysomerase 2 and 4, |
| 1:40.2 | so the different subtypes. |
| 1:42.4 | Topo isopoisomerase 2 is the primary enzyme responsible for maintaining that DNA helical or superheylical structure. |
| 1:53.1 | And that maintenance of managing that structure of the DNA is absolutely necessary for replication, |
| 2:02.8 | transcription, repair, and ultimately kind of growth of the infection. |
| 2:09.5 | So this is an antibiotic for infection, obviously, |
| 2:13.8 | and it is considered a broad spectrum antibiotic in general. |
| 2:19.5 | It's got some coverage on gram positives. |
| 2:22.9 | It's got some coverage on gram negatives. |
| 2:25.3 | Also has a decent anaerobic coverage as well. |
... |
Transcript will be available on the free plan in 16 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.